SUCCESSFUL USE OF RIFAMPICIN IN THE TREATMENT OF TUBERCULOSIS IN RENAL TRANSPLANT PATIENTS IMMUNOSUPPRESSED WITH CYCLOSPORINE

Abstract
Cyclosporine and rifampicin were used simultaneously in 6 renal transplant patients with tuberculosis. The total daily dose of cyclosporine had to be increased 3-5-fold, with the frequency of administration increased from twice to thrice daily. With this regimen, satisfactory cyclosporine levels were attained and there was no adverse affect on graft function.

This publication has 0 references indexed in Scilit: